1. Primary hyperphosphatemic tumoral calcinosis: a case report
- Author
-
T.-R. Zhang, S.-M. Li, Qingqi Meng, J. Huang, and L.-G. Cao
- Subjects
medicine.medical_specialty ,Primary Hyperphosphatemic Tumoral Calcinosis ,business.industry ,Endocrinology, Diabetes and Metabolism ,Soft tissue ,medicine.disease ,Rheumatology ,Internal medicine ,Orthopedic surgery ,medicine ,Tumoral calcinosis ,Radiology ,Acetazolamide ,business ,Rare disease ,medicine.drug ,Calcification - Abstract
Tumoral calcinosis (TC) is a rare disease characterized by periarticular soft tissue calcification. Some cases were reported in Africa and the Middle East. We report an 11-year-old Chinese girl presenting with recurrent multiple subcutaneous masses around the right elbow and hip regions. Although we found abnormalities in FGF23, a protein associated with phosphate metabolism, no positive results were observed in gene sequencing and analysis. The imaging features, laboratory examination, and pathology results confirmed our diagnosis. By using oral phosphorus-lowering drugs (acetazolamide) combined with complete surgical excision, good results were achieved, and no recurrence was reported during the follow-up of 18 months. We report a case of primary hyperphosphatemic TC. The combined use of oral phosphorus-lowering drugs (acetazolamide) and complete surgical excision produced good results, and no recurrence was reported during the follow-up of 18 months.
- Published
- 2021